Applications for  CRUK CoL Centre  Clinical Research Training Fellowships commencing in September 2024 are closed now. 

This is a unique multidisciplinary and collaborative training opportunity for any clinician who is interested in carrying out research in cancer biotherapeutics.

The appointed fellows will follow the three-year version of the CRUK CoL PhD training programme, which provides a firm foundation for clinicians with a future academic career path in mind. They will follow a customised training plan, developed in collaboration with their supervisors and tailored to their background and project requirements. Trainees will benefit from multi-disciplinary scientific and cohort-building activities, and actively participate in the Centre’s events, e.g. symposia, conferences.

We are looking for talented and motivated clinicians who are passionate about research, have a strong academic track record and hold full GMC registration or equivalent. We expect applicants to be in a training position. These are full-time research positions with limited participation in clinical activities. They are fully funded for three years, and PhD registration will be at the primary supervisor’s university. Successful candidates will receive a salary commensurate with their current experience, paid on the clinical academic scale.

The funding for this fellowship covers students with home tuition fee status only. For more information on home tuition fee status please visit the UKCISA website. Please note that we will only be able to offer fellowships to candidates that have home tuition fee status or provide evidence that they can fund the international portion of the tuition fee from external sources (i.e. not self-funded).

Applications must be submitted through the Francis Crick Institute’s online academic recruitment system. 

Before beginning an application, you should read the information on this page and the completing the application form page. You can find out about the projects being offered to start in September 2024 and their supervisor below.

• Your application must be submitted by the deadline: 14 February 2024, noon
• We should receive your references by 21 February 2024, noon. Your application may still be considered if references are not received by this deadline. However, no applicant will be invited to interview unless references have been received.
• You will find out if you have been invited to interview for the programme before: 9 April 2024
  
• Supervisors may contact you during the shortlisting period (late mid November to mid December), to find out more about you and your interest in their project.
• Information session for interviewees: 15 April 2024, 12pm to 1pm
• Panel interviews will take place: w/c 22 April 2024
  
• Programme start date:  September 2024

During the interview, candidates will be interviewed by a panel of CRUK CoL Centre academics from across the Centre’s partners. Please note that not all projects will be funded and studentships will be awarded to the best applicants based on information submitted on the application form, references and performance during the interview.

Project 1: Characterisation of metabolic heterogeneity and evolution in IDH-mutant AML in response to targeted therapies

Primary Supervisor: Paolo Gallipoli, Queen Mary University of London Co-supervisor: Lynn Quek, King’s College London

Project 2: Molecular and clinical correlates of quantitative morphological atypia

Primary Supervisor: Mariam Jamal-Hanjani, UCL Co-supervisors: Anita Grigoriadis, King’s College London; David Moore, UCL

Project 3: Epigenetic repression of inflammatory cytokine production by oncogenic fusion proteins in endometrial stromal sarcoma

Primary Supervisor: Richard Jenner, UCL Co-supervisor: Michelle Lockley, Queen Mary University of London

Project 4: Artificial intelligence and bioinformatics approaches to assess predictive biomarkers for immunotherapy and investigate optimum treatment combinations in metastatic breast cancer

Primary Supervisor: Anthony Kong, King’s College London Co-supervisor: Teresa Marafioti, UCL, Heba Sailem, King’s College London

Project 5: Uncovering the role of RNA regulator MYBBP1A in acute myeloid leukaemia

Primary Supervisor: Diu Nguyen, Queen Mary University of London Co-supervisor: Eric So, King’s College London

Project 6: Understanding the evolution of extrachromosomal DNA through treatmnent and metastastic progression

Primary Supervisor: Charles Swanton, Francis Crick Institute Co-supervisor: Benjamin Werner, Queen Mary University of London

Project 7: Cancer recognition code of gamma-delta T-cells

Primary Supervisor: Yin Wu, King’s College London Co-supervisor: Marco Gerlinger, Queen Mary University of London

Project 8: Impact of co-occurring del(1p)/gain(1q) events in the evolution of multiple myeloma

Primary Supervisor: Kwee Yong, UCL Co-supervisor: Dinis Calado, The Francis Crick Institute